Form Type:  6-K
Filing Date:  5/16/2018 
CIK:  0001674988 
Address:  SMEDELAND 36
City, State, Zip:  COPENHAGEN,  00000 
Telephone:  (458) 877-3600 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
-0.07 (-0.47%)  
Trade Time: 
Jan 23  
Market Cap: 
Trade ZEAL now with

© 2019  
Description of Business
We were founded in 1998 and is a biotechnology company focused on the discovery, design and development of innovative peptide-based medicines. We intend to be a leader in specialty medicines focusing on metabolic and gastrointestinal diseases and other specialty disease areas with significant unmet medical needs. We have a portfolio of medicines and product candidates under license collaborations with Sanofi and Boehringer Ingelheim. Our pipeline focuses on gastrointestinal, metabolic and other specialty diseases where we believe that the present standard of care is inadequate and where we have the resources to advance our peptide-based product candidates into the later stages of clinical development, including registration and commercialization, while opportunistically considering partnership relationships that may arise. We have a track record of successfully inventing and developing novel peptide-based product candidates.
Register and access this filing in:     
  FORM 6-K
  EXHIBIT 99.1
    Note 1 - Significant accounting policies and significant ...
  EXHIBIT 99.2